Press Release Archives

Press Release

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

New offering provides strategic guidance and AI-enabled biosimulation to navigate FDA’s Roadmap to Reducing Animal…

CertaraApril 14, 2025

Press Release

Certara Reports Preliminary First Quarter 2025 Financial Results Announces $100 Million Share Repurchase Authorization

Reiterates Full-Year 2025 Guidance Arsenal Capital Partners agrees to a one-year lock-up RADNOR, PA —…

CertaraApril 14, 2025

Press Release

Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

RADNOR, PA — April 1st, 2025 – Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraApril 1, 2025

Press Release

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

March 5, 2025 McKemey joins Certara to accelerate growth of its strategic drug development solutions …

CertaraMarch 5, 2025

Press Release

Certara Reports Fourth Quarter 2024 Financial Results

February 26, 2025 Issues Full Year 2025 Financial Guidance RADNOR, PA – February 26, 2025 – Certara,…

CertaraFebruary 26, 2025

Press Release

Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences

January 29, 2025 Radnor, Pa. — January 29th, 2025 — Certara, Inc. (Nasdaq: CERT), a global…

CertaraJanuary 29, 2025

Press Release

Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results

January 15, 2025 Full-Year 2024 Revenue of $384.4 million, Bookings of $445.3 million Confirms Adjusted…

CertaraJanuary 15, 2025

Press Release

Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

January 2, 2025 RADNOR, Pa. — January 2, 2025 — Certara, Inc. (Nasdaq: CERT), a global leader…

CertaraJanuary 2, 2025

Press Release

Certara Showcases 2024 Research Wins with Over 100 Papers Published

The company celebrates the 12 scientists included in the Stanford/Elsevier top 2% cited researchers list …

CertaraDecember 2, 2024

Press Release

Certara Reports Third Quarter 2024 Financial Results

Updates Full Year 2024 Financial Guidance RADNOR, PA — November 6, 2024-- Certara, Inc. (Nasdaq: CERT),…

CertaraNovember 6, 2024

Press Release

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

Certara Reports Preliminary First Quarter 2025 Financial Results Announces $100 Million Share Repurchase Authorization

Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

Certara Reports Fourth Quarter 2024 Financial Results

Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences

Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results

Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Certara Showcases 2024 Research Wins with Over 100 Papers Published

Certara Reports Third Quarter 2024 Financial Results

Newsletter sign up

Quick links

Solutions

Contact